Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
Wickstrøm
Jannie
J
MUUSMANN (COWI), Kolding, Denmark.
Dam
Nanna
N
Malmberg
Irena
I
Hansen
Brian Bekker
BB
Lange
Peter
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001249:Asthma / Q000188:drug therapy* / Q000191:economics*; D001993:Bronchodilator Agents / Q000191:economics* / Q000627:therapeutic use; D019819:Budesonide / Q000191:economics* / Q000627:therapeutic use; D002648:Child; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003718:Denmark; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D017850:Economics, Pharmaceutical; D004983:Ethanolamines / Q000191:economics* / Q000627:therapeutic use; D005260:Female; D000068759:Formoterol Fumarate; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic
D001993:Bronchodilator Agents; D004338:Drug Combinations; D004983:Ethanolamines; D019819:Budesonide; D000068759:Formoterol Fumarate